Skip to main content
Journal cover image

Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?

Publication ,  Journal Article
Goyal, A; Blazing, M
Published in: Am Heart J
October 2005

Duke Scholars

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

October 2005

Volume

150

Issue

4

Start / End Page

650 / 651

Location

United States

Related Subject Headings

  • Risk Factors
  • Middle Aged
  • Male
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Evidence-Based Medicine
  • Coronary Disease
  • Cardiovascular System & Hematology
  • C-Reactive Protein
  • 3201 Cardiovascular medicine and haematology
 
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

October 2005

Volume

150

Issue

4

Start / End Page

650 / 651

Location

United States

Related Subject Headings

  • Risk Factors
  • Middle Aged
  • Male
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Evidence-Based Medicine
  • Coronary Disease
  • Cardiovascular System & Hematology
  • C-Reactive Protein
  • 3201 Cardiovascular medicine and haematology